Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800014309Phase 4Recruiting
Phase 4, open-label trial of tranexamic acid in intertrochanteric fracture (2 arms), sponsored by The People's Hospital of Leiyang. Primary endpoint: hidden blood loss. Started Jan 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800014309.